Navigation Links
Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
Date:4/8/2013

bone marrow. This is important because existing therapies often fail to effectively eliminate cancer cells in these tissue sites. Targeted therapy for CLL is becoming a reality, and this new approach may greatly improve the lives of patients with this disease."

The study also evaluated in vivo effects of ibrutinib using blood and tissue samples collected before and during treatment. Ibrutinib demonstrated rapid and sustained disease control in blood, lymph nodes, spleen and bone marrow. After 6 months, 95 percent of patients experienced a reduction in lymph node size and all showed reduction in spleen enlargement, with a median reduction of 55 percent. In 26 patients, for whom a bone marrow biopsy was done, tumor infiltration decreased by 82 percent.

The Progression Free Survival probability for these patients at 12 months was estimated to be 94 percent. Most adverse events were mild and manageable and included diarrhea, fatigue and rash, severe events occurred in less than 13 percent of patients. 

"We are very pleased with the continued research that is being demonstrated at AACR across 9 different presentations. These advances show the potential breadth of the ibrutinib program and provide further opportunities for us to pursue. We are grateful for the continued support of our collaborators, investigators, patients and shareholders," said Bob Duggan , CEO and chairman of the board.

Ibrutinib has been designated as a FDA Breakthrough Therapy in CLL patients with deletion 17p, based on data from completed Phase I/II clinical studies, where ibrutinib as a monotherapy was used to treat patients with this disease. Ibrutinib has the potential to improve the outcome in this serious and life-threatening disease, and may provide a substantial improvement over existing therapies for this indication.

About Chronic Lymphocytic Leukemia

CLL is the most common type of leukemia, a cancer of the whi
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
(Date:9/19/2014)... Fla. , Sept. 19, 2014  The body ... with the publication of two papers this past week.  ... – Head and Neck Surgery , finds that ... and subjective measures of sleep disordered breathing, leading the ... reduction in obstructive sleep apnea severity and improvement of ...
(Date:9/19/2014)... 19, 2014 Intarcia Therapeutics, Inc. ... for its lead candidate ITCA 650 (continuous subcutaneous delivery ... baseline HbA1c levels at the 50 th Annual ... Diabetes (EASD). Data from the open-label, phase 3 FREEDOM-HBL ... sugar in patients with poorly controlled type 2 diabetes. ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... , SAN DIEGO, Sept. 8 ... ("Stemedica"), a world leader in stem cell research and manufacturing, ... and Trademark Office ("USPTO") for a proprietary methodology in the ... the USPTO on August 27th of this year. The ...
... MELBOURNE, Australia, Sept. 3 Cytopia Limited,s (ASX: CYT) ... Food and Drug Administration (FDA) review. CYT387 is a small-molecule ... The company,s IND application is now active and Cytopia is ... United States. , , CYT387 will be ...
Cached Medicine Technology:United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy 2United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy 3Cytopia's CYT387 Receives FDA Clearance to Start US Clinical Trials 2
(Date:9/21/2014)... 2014 "I wanted to be able ... consume sugary, foul-tasting energy drinks," said an inventor from ... want to drink plain, old coffee. That is why ... He developed ENERG CHEWING GUM to provide a healthy ... The formula contains nutritious vitamins, minerals and antioxidants. It ...
(Date:9/21/2014)... 2014 "I want to help people ... but haven’t the money for chiropractors," said an inventor ... such a product for myself." , The Stretch is ... the thigh muscles and align the spine properly. It ... discomfort of pinched nerves. Compact and easy to use, ...
(Date:9/21/2014)... Best Cheap Hosting USA, one of the ... and GreenGeeks are the best Reseller hosting suppliers in ... hosting supplier. Actually, these companies have outperformed their competitors ... People can get the best web hosting at affordable ... to the manager, reseller hosting is a very popular ...
(Date:9/21/2014)... 2014 To accommodate the ever-growing customer ... provide more trendy items. Recently, the company has unveiled ... the new and elegant wedding gowns, Angeldress.co.uk wants to ... need in an easy way. Its high quality vintage ... from 12% off to 62% off. , Online shopping ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 “Cluster headaches ... so intense and difficult to resolve,” said Steve Young ... can't think of a pain that is more intense.” ... suffers from cluster headaches, or migraines, that medical research ... the serotonin system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Announces The Best Reseller Hosting Suppliers In 2014 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2
... ... ... , ... , ...
... ... ... , ... ...
... , ... ... ... ...
... ... ... ... ...
... choking off blood supply to the brain, every minute counts: ... left untreated, making it a race to recognize symptoms so ... Americans 135 million people -- are more than an ... best equipped to care for them if they are stricken ...
... neutrons are poised to play a big role in ... The reason: They are the focus of a process ... the chemistry of a wide range of important materials, ... article in Chemical & Engineering News (C&EN), ...
Cached Medicine News:Health News:Restaurants, C-Stores and Retailers Defy the Challenging Economy Raising A Record $5.6 Million During Annual St. Jude Halloween Promotion 2Health News:Restaurants, C-Stores and Retailers Defy the Challenging Economy Raising A Record $5.6 Million During Annual St. Jude Halloween Promotion 3Health News:Restaurants, C-Stores and Retailers Defy the Challenging Economy Raising A Record $5.6 Million During Annual St. Jude Halloween Promotion 4Health News:Restaurants, C-Stores and Retailers Defy the Challenging Economy Raising A Record $5.6 Million During Annual St. Jude Halloween Promotion 5Health News:Restaurants, C-Stores and Retailers Defy the Challenging Economy Raising A Record $5.6 Million During Annual St. Jude Halloween Promotion 6Health News:New Ankle Arthritis Treatments Help Boomers Stay Active 2Health News:New Ankle Arthritis Treatments Help Boomers Stay Active 3Health News:New Ankle Arthritis Treatments Help Boomers Stay Active 4Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 2Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 3Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 4Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 5Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 6Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 7Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 8Health News:The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite 'N Day Festival Celebrates the Year of the Tiger This Weekend 9Health News:SeqWright Advances Genomic Discovery With Isilon IQ 2Health News:SeqWright Advances Genomic Discovery With Isilon IQ 3Health News:SeqWright Advances Genomic Discovery With Isilon IQ 4Health News:SeqWright Advances Genomic Discovery With Isilon IQ 5Health News:SeqWright Advances Genomic Discovery With Isilon IQ 6Health News:SeqWright Advances Genomic Discovery With Isilon IQ 7Health News:Half of Americans live more than an hour away from lifesaving stroke care 2Health News:Half of Americans live more than an hour away from lifesaving stroke care 3
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
... Focus from Thermo Labsystems was ... with uncompromising performance. The ... a custom fit for different ... tip cones allow easier and ...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
Medicine Products: